MIRECC Staff: Mehmet Sofuoglu, M.D. ...

Dr. Mehmet Sofuoglu, M.D., Ph.D.

Claim this profile

VA Healthcare System

Studies Smoking Addiction
Studies Nicotine Addiction
5 reported clinical trials
5 drugs studied

Affiliated Hospitals

Image of trial facility.
VA Healthcare System
Image of trial facility.
Department Of Veterans Affairs Hospital

Clinical Trials Mehmet Sofuoglu, M.D., Ph.D. is currently running

Image of trial facility.

Dronabinol

for Pain Management in Opioid Users

Twenty male and female (ages 18-70) participants with OUD currently receiving methadone or buprenorphine will be enrolled. Prior to their daily methadone or buprenorphine dose and thus at trough plasma levels of opioid, participants will receive dronabinol (2.5 mg, 5mg) or placebo. Subsequently, all participants will undergo laboratory testing of opioid-related outcomes. Pain sensitivity will be measured using a technique called the (QST) quantitative sensory testing, which involves the administering heat or cold stimulation. A Short-Form McGill Pain Questionnaire (SF-MPQ) and a pain Visual Analog Scale (VAS). Attentional bias will be measured using a visual probe task. Negative affect will be measured using the Positive and Negative Affect Schedule (PANAS). Cognitive performance will be measured by a comprehensive cognitive battery. The order of study medication administration will be counterbalanced order to minimize carryover effects. On the initial screening day and at the end of medication treatment, blood will be drawn to determine serum cytokine levels. One week after the last study medication dose, a follow-up session will be conducted during which participants will undergo urine toxicology testing and a safety evaluation before final discharge from the study.
Recruiting0 awards Phase < 1
Image of trial facility.

Nicotine Thresholds

for Smoking Addiction

To determine the nicotine threshold dose(s) for discrimination, subjective-rewarding effects, -and reinforcement in smokers with different levels of dependence.
Recruiting0 awards Phase < 18 criteria

More about Mehmet Sofuoglu, M.D., Ph.D.

Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Mehmet Sofuoglu, M.D., Ph.D. has experience with
  • Nicotine
  • Dronabinol
  • Placebo
  • Cannabidiol
  • Saline

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Mehmet Sofuoglu, M.D., Ph.D. specialize in?
Is Mehmet Sofuoglu, M.D., Ph.D. currently recruiting for clinical trials?
Are there any treatments that Mehmet Sofuoglu, M.D., Ph.D. has studied deeply?
What is the best way to schedule an appointment with Mehmet Sofuoglu, M.D., Ph.D.?
What is the office address of Mehmet Sofuoglu, M.D., Ph.D.?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security